of the form that we needed for success was: 1) fully
compliant with Joint Commission standards; 2) easy
to create, edit, and maintain; 3) easy to read, full-
color, and a single page; 4) easy for anyone to view
and print; 5) easy to access reference materials; 6)
easy to access home medication lists; and 7) easy to
access a complete audit trail of the form
3 RESULTS
Our compliance data is shown in figure 2 and Table
1. Our highest baseline compliance using the paper
asthma action plan was 32%. The electronic asthma
action plan contained pick lists and check boxes for
much of the data entry. It also contained hyperlinks
to NIH asthma guidelines and a link to display the
patient’s current medication list present in the EMR.
After the electronic asthma action plan was
implemented, our compliance increased to 45%.
Upon reviewing the compliance data, we noted
continued deficiencies in the following required
documentation fields: 1) asthma type, 2) asthma
triggers, 3) the name and phone number of the
patient’s primary care physician when that provider
Figure 2: Compliance Over Time.
was not present within our existing database, and 4)
the specific date and time (or time frame) of
discharge follow-up. We added visible
recommendation flags to the areas of the form where
these items are entered. Users were educated and the
revised form was implemented. Compliance
following these changes increased from 45% to 70%
with these modifications. Our compliance data is
shown in figure 2.
After evaluating the compliance data following the
second iteration and receiving input from the users,
we identified additional barriers to compliance. This
included continued poor documentation of inpatient
Table 1: Compliance changes through 3 cycles.
Compliance
Pre QI 32%
After Iteration 1 45%
After Iteration 2 70%
After Iteration 3 90%
follow up information, placing inpatient follow up
information in the outpatient forms, and complaints
by users about repetitive actions. To address these
issues, we enabled functionality with the form to
default a standard post-discharge follow up time
frame if not specified, to hide the inpatient follow up
section of the form entirely when accessed from an
outpatient encounter, and created quick macro
buttons to populate common combinations of
medication therapies for user convenience.
Following the introduction of these changes,
compliance rose again from 70% to 90%.
4 DISCUSSION
Based on our experience, transitioning to an
electronic asthma action plan provides for
functionality and access that improves overall
compliance. However, merely the implementation of
an electronic equivalent of the paper form within our
EMR was not sufficient to substantially improve
compliance. According to the users, the electronic
form was somewhat easier to use than the paper
version and was more readily available, but still
suffered limitations and barriers to regular
completion. It was easier to use because it contained
pick lists for rapid documentation of items such has
asthma type, asthma triggers, and medications
including dose, route and frequency. It also
contained useful links including one to the NIH
guideless for asthma care and one to the patient’s
current medication list. However, these features
only increased overall compliance by 13%.
Part of the PDCA cycle is to Check (evaluate
what happened). Along with our audit, we discussed
with the users what they found helpful with the
electronic version and what improvements they
would fine useful. With this feedback, we added
additional functionality in the form of visual
indicators to direct the user’s attention to items often
overlooked. The reminders did improve the
compliance by 20%. However, we still were only
getting the forms fully completed 70% of the time as
indicated by our audit following the introduction of
this additional functionality.
LeveraginganElectronicMedicalRecordtoImproveCompliancewithPediatricAsthmaCareDocumentation
321